DAIICHI SANKYO ESPANA, S.A. secures contract for Various Medicinal Products - The object of the contract is determined by the supply of the active substance called "TRASTUZUMABDERUXTECAN 100MG VIAL PERFUSION IV"

Spain, March 10 -- Spain based DAIICHI SANKYO ESPANA, S.A. has secured contract from Direccion del Servicio Canario de Salud for Various Medicinal Products - The object of the contract is determined by the supply of the active substance called "TRASTUZUMABDERUXTECAN 100MG VIAL PERFUSION IV". The value of the contract is worth 81770325 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....